Chapter 4 Cell death in models of spinal cord injury

https://doi.org/10.1016/S0079-6123(02)37006-7Get rights and content

Abstract

Current treatments for acute spinal cord injury are based on animal models of human spinal cord injury (SCI). These models have shown that the initial traumatic injury to cord tissue is followed by a long period of secondary injury that includes a number of cellular and biochemical cascades. These secondary injury processes are potential targets for therapies. Continued refinement of rat and mouse models of SCI, along with more detailed analyses of the biology of the lesion in these models, points to both necrotic and apoptotic mechanisms of cell death after SCI. In this chapter, we review recent evidence for long-term apoptotic death of oligodendrocytes in long tracts undergoing Wallerian degeneration following SCI. This process appears to be related closely to activation of microglial cells. It is has been thought that microglial cells might be the source of cytotoxic cytokines, such as tumor necrosis factor-α (TNF-α), that kill oligodendrocytes. However, more recent evidence in vivo suggests that TNF-α by itself may not induce necrosis or apoptosis in oligodendrocytes. We review data that suggests other possible pathways for apoptosis, such as the neurotrophin receptor p75 which is expressed in both neurons and oligodendrocytes after SCI in rats and mice. In addition, it appears that microglial activation and TNF-a may be important in acute SCI. Ninety minutes after a moderate contusion lesion, microglia are activated and surround dying neurons. In an ‘atraumatic’ model of SCI, we have now shown that TNF-α appears to greatly potentiate cell death mediated by glutamate receptors. These studies emphasize that multiple mechanisms and interactions contribute to secondary injury after SCI. Continued study of both contusion models and other new approaches to studying these mechanisms will be needed to maximize strategies for acute and chronic therapies, and for neural repair.

References (91)

  • K.D. Dougherty et al.

    Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury

    Neurobiol. Dis.

    (2000)
  • M.G. Fehlings et al.

    The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury

    Exp. Neural.

    (1995)
  • S.D. Grossman et al.

    Relationship of altered glutamate receptor subunit mRNA expression to acute cell loss after spinal cord contusion

    Exp. Neurol.

    (2001)
  • S.M. Hall et al.

    Tumor necrosis factor-alpha has morphological effects within the dorsal columns of the spinal cord in contrast to its effect in the peripheral nervous system

    J. Neuroimmunol.

    (2000)
  • G.E. Hermann et al.

    Tumor necrosis factor induces cFOS and strongly potentiates glutamate-mediated cell death in rat spinal cord

    Neurobiol. Dis.

    (2001)
  • C.E. Hill et al.

    Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat

    Exp. Neurol.

    (2001)
  • S. Nagata

    Apoptosis by death factor

    Cell

    (1997)
  • L. Noble et al.

    Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord

    Exp. Neurol.

    (1985)
  • B.T. Stokes et al.

    Extracellular calcium activity in the injured spinal cord

    Exp. Neurol.

    (1983)
  • C.X. Wang et al.

    Increase of interleukin-1 beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat

    Brain Res.

    (1997)
  • P. Warden et al.

    Delayed glial cell death following Wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats

    Exp. Neurol.

    (2001)
  • J.R. Wrathall et al.

    Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-Nmethyl-d-aspartate receptors

    Exp. Neurol.

    (1996)
  • J.R. Wrathall et al.

    Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma

    Exp. Neurol.

    (1997)
  • J. Xu et al.

    Methylprednisolone inhibition of TNF-α expression and NFκB activation after spinal cord injury in rats

    Mol. Brain Res.

    (1998)
  • Y. Abe et al.

    Apoptotic cells associated with Wallerian degeneration after experimental spinal cord injury: a possible mechanism of oligodendroglial death

    J. Neurotrauma

    (1999)
  • P.M. Arnold et al.

    Caspase-3 inhibition is neuroprotective after spinal cord injury

    J. Neurochem.

    (2000)
  • J.D. Balentine

    Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury

    Lab. Invest.

    (1978)
  • J.D. Balentine

    Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin

    Lab. Invest.

    (1978)
  • B.A. Barres et al.

    Cell death in the oligodendrocyte lineage

    J. Neurobiol.

    (1992)
  • D.M. Basso et al.

    Histological and locomotor studies of graded spinal cord contusion using the NYU weight-drop device versus transection

    Exp. Neurol.

    (1996)
  • M.S. Beattie et al.

    Cell death, repair, and recovery of function after spinal cord contusion injuries in rats

  • M.S. Beattie et al.

    Expression of p75 NTFR in neurons and oligodendrocytes after spinal cord injury in rats: neurotrophin-induced apoptosis in vivo?

    Soc. Neurosci. Abstr.

    (1999)
  • M.S. Beattie et al.

    A review of current evidence for apoptosis after spinal cord injury

    J. Neurotrauma

    (2000)
  • M.S. Beattie et al.

    TNF, glutamate and neurodegeneration in the rat spinal cord

    Soc. Neurosci. Abstr

    (2000)
  • D.L. Behrmann et al.

    Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis

    J. Neurotrauma

    (1992)
  • J.R. Bethea et al.

    Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats

    J. Neurotrauma

    (1999)
  • M.B. Bracken et al.

    Efficacy of methylprednisolone in acute spinal-cord injury

    J. Am. Med. Assoc.

    (1984)
  • M.B. Bracken et al.

    A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury

    New Engl. J. Med.

    (1990)
  • M.B. Bracken et al.

    Administration of methylprednisolone for 24 or 48 hours or tirilizad mesylate for 48 hours in the treatment of acute spinal cord injury — results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial

    J. Am. Med. Assoc.

    (1997)
  • R.P. Bunge et al.

    Observations of the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of cord compression with extensive focal demyelination

    Adv. Neurol.

    (1993)
  • E.A. Carswell et al.

    An endotoxin-induced serum factor that causes necrosis of tumors

  • P. Casaccia-Bonnefil et al.

    Neurotrophins: the biological paradox of survival factors eliciting apoptosis

    Cell Death Differ.

    (1998)
  • S. Constantini et al.

    The effects of methylprednisolone and the ganglioside GMI on acute spinal cord injury in rats

    J. Neurosurg.

    (1994)
  • M.J. Crowe et al.

    Morphological evidence suggesting apoptotic nuclei in spinal cord injury

    Soc. Neurosci. Abstr.

    (1995)
  • M.J. Crowe et al.

    Apoptosis and delayed degeneration after spinal injury in rats and monkeys

    Nat. Med.

    (1997)
  • Cited by (387)

    View all citing articles on Scopus
    View full text